Clinical Guest Contributors

  1. No Surprise Here: Experts Value Clinical Relevance Over Statistical Relevance 12/31/2025

    Experts weighed in: “Agree or disagree? Statistical significance is preferable to clinical relevance.”

  2. Trial Matching, Source Data, And More: How Clinical Researchers Used AI In 2025 12/30/2025

    Researchers reflect on the past year and share how they used AI for clinical research in 2025.

  3. CRO Industry Outlook 2026: The Next Stage Of Clinical Trial Transformation 12/30/2025

    Beroe research manager Mathini Ilancheran reflects on the advances in AI, the rise of APAC as a global trial hub, new regulatory expectations, and increasing scientific complexity and forecasts how they will impact CROs in the coming year.

  4. Mock Inspection Advice From Former Regulatory Investigator 12/30/2025

    Former FDA investigator Alia Legaux, D.H.Sc., runs through her top tips for running a mock investigation.

  5. FDA Further Expands And Clarifies Expanded Access FAQs 12/29/2025

    Healthcare attorney Dianne J. Bourque breaks down the FDA's October 2025 update to its Expanded Access FAQs.

  6. The Rise Of Antimicrobial Resistance And Strategic Research Imperatives For 2026 12/26/2025

    Antimicrobial resistance (AMR) has increasingly worried public health officials and researchers alike in 2025. Now, in 2026, TAXI Pharmaceutical President and CEO Gregory G. Mario, MBA, is calling for more targeted approaches and the integration of AI for quicker discovery and development.

  7. Is Your Team Burnt Out? Discover The ROI Of Healthy Employees Running Trials 12/23/2025

    Clinical trials require attention to detail, but one key variable is often overlooked: the physical, mental, and emotional wellbeing of the people behind the science and operations. How can companies make sure their workforce is ready and able to perform in high-stakes drug development?

  8. 6 Pillars To Support Community Hospitals' First Steps Into Clinical Trials 12/22/2025

    Discover six pillars community hospitals can leverage to make a compelling case for clinical trials: dedicated infrastructure, community engagement, technology platforms, financial support, strategic partnerships, and physician engagement.

  9. Most Ex-U.S. Countries Can't Access The Medicines They Help Study 12/19/2025

    When a country hosts a clinical trial, we assume patients there will eventually benefit from the therapy they helped test. Research Jennifer E. Miller, Ph.D., says that's not often the case.

  10. More Patient Insight — And Funding— Needed To Advance Preeclampsia Research 12/18/2025

    Preeclampsia Foundation’s Laney Poye discusses the urgent need for sustained preeclampsia research funding, patient-informed trial design, and stronger partnerships between advocacy groups and biopharma.